Shares of JPMorgan U.S. Momentum Factor ETF (NYSEARCA:JMOM – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $69.75 and last traded at $69.8030, with a volume of 16137 shares changing hands. The stock had previously closed at $69.30.
JPMorgan U.S. Momentum Factor ETF Price Performance
The stock has a market capitalization of $1.79 billion, a P/E ratio of 27.64 and a beta of 1.04. The stock’s fifty day moving average is $68.34 and its 200-day moving average is $66.77.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the stock. Hazlett Burt & Watson Inc. bought a new stake in JPMorgan U.S. Momentum Factor ETF during the third quarter worth approximately $44,000. Smartleaf Asset Management LLC lifted its stake in shares of JPMorgan U.S. Momentum Factor ETF by 334.8% in the second quarter. Smartleaf Asset Management LLC now owns 687 shares of the company’s stock worth $44,000 after buying an additional 529 shares during the last quarter. Abich Financial Wealth Management LLC bought a new stake in shares of JPMorgan U.S. Momentum Factor ETF during the 3rd quarter worth $51,000. Fifth Third Bancorp acquired a new position in JPMorgan U.S. Momentum Factor ETF in the 3rd quarter valued at $55,000. Finally, Root Financial Partners LLC bought a new position in JPMorgan U.S. Momentum Factor ETF in the 3rd quarter worth $87,000.
About JPMorgan U.S. Momentum Factor ETF
The JPMorgan U.S. Momentum Factor ETF (JMOM) is an exchange-traded fund that is based on the JP Morgan US Momentum Factor index. The fund tracks an index of US large-cap companies with strong momentum, weighted by optimized market-cap. JMOM was launched on Nov 8, 2017 and is managed by JPMorgan Chase.
Featured Stories
- Five stocks we like better than JPMorgan U.S. Momentum Factor ETF
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- YDES Could Be 2026’s Biotech Breakthrough
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for JPMorgan U.S. Momentum Factor ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan U.S. Momentum Factor ETF and related companies with MarketBeat.com's FREE daily email newsletter.
